Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARGO Colchicine in Acute Myocarditis
2024-514610-13-00Phase 3Authorised
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2024
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute myocarditis comparing Colchicine with Placebo (2 arms). Planned start Oct 2024; status: authorised.
02
Drugs
colchicine
03
Conditions
acute myocarditis
Beyond the preview
Go deeper on 2024-514610-13-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514610-13-00.